Literature DB >> 15190975

Admission and discharge guidelines for the pediatric patient requiring intermediate care.

David G Jaimovich1.   

Abstract

During the past three decades, the specialty of pediatric critical care medicine has grown rapidly, leading to a number of pediatric intensive care units being opened across the country. Many patients who are admitted to the hospital require a higher level of care than the routine inpatient general pediatric care, yet not to the degree of intensity as pediatric critical care; therefore, an intermediate care level has been developed in institutions providing multiple disciplinary subspecialty pediatric care. These patients may require frequent monitoring of vital signs and nursing interventions but usually do not require invasive monitoring. The admission of the pediatric intermediate care patient is guided by physiologic parameters depending on the respective organ system involved relative to the institution's resources and capacity in caring for a patient in a general care environment. This report provides admission and discharge guidelines for intermediate pediatric care. Intermediate care promotes greater flexibility in patient triage and provides a cost-effective alternative to admission to a pediatric intensive care unit. This level of care may enhance the efficiency of care and improve the healthcare affordability for patients receiving intermediate care.

Entities:  

Mesh:

Year:  2004        PMID: 15190975     DOI: 10.1097/01.ccm.0000126001.23141.4f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  2 in total

1.  Continuous Albuterol in Pediatric Acute Care: Study Demonstrates Safety Outside the Intensive Care Unit.

Authors:  Amanda F Messer; Esther M Sampayo; Brent Mothner; Elizabeth A Camp; Jennifer Jones; Terri Brown; Joyee Vachani
Journal:  Pediatr Qual Saf       Date:  2019-12-05

2.  Hospital use of young children in Switzerland: a nation-wide study based on a complete survey over 4 years.

Authors:  Franziska V Schoeni-Affolter; Marcel Widmer; André Busato
Journal:  BMC Health Serv Res       Date:  2008-12-20       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.